img

Global Fragment-based Drug Discovery Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Fragment-based Drug Discovery Market Research Report 2024

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
According to MRAResearch’s new survey, global Fragment-based Drug Discovery market is projected to reach US$ 533.8 million in 2033, increasing from US$ 332.8 million in 2022, with the CAGR of 6.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fragment-based Drug Discovery market research.
Key companies engaged in the Fragment-based Drug Discovery industry include Astex Pharmaceuticals, Alveus Pharmaceuticals, Beactica, Charles River Laboratories, Crown Bioscience, Emerald BioStructures, Evotec, Kinetic Discovery and Proteros Fragments, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Fragment-based Drug Discovery were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Fragment-based Drug Discovery market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Fragment-based Drug Discovery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery
Segment by Type
Fragment Screening
Fragment Optimization

Segment by Application


Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Fragment-based Drug Discovery report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Fragment Screening
1.2.3 Fragment Optimization
1.3 Market by Application
1.3.1 Global Fragment-based Drug Discovery Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Academic and Research Institutions
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fragment-based Drug Discovery Market Perspective (2018-2033)
2.2 Fragment-based Drug Discovery Growth Trends by Region
2.2.1 Global Fragment-based Drug Discovery Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Fragment-based Drug Discovery Historic Market Size by Region (2018-2023)
2.2.3 Fragment-based Drug Discovery Forecasted Market Size by Region (2024-2033)
2.3 Fragment-based Drug Discovery Market Dynamics
2.3.1 Fragment-based Drug Discovery Industry Trends
2.3.2 Fragment-based Drug Discovery Market Drivers
2.3.3 Fragment-based Drug Discovery Market Challenges
2.3.4 Fragment-based Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fragment-based Drug Discovery Players by Revenue
3.1.1 Global Top Fragment-based Drug Discovery Players by Revenue (2018-2023)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2018-2023)
3.2 Global Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fragment-based Drug Discovery Revenue
3.4 Global Fragment-based Drug Discovery Market Concentration Ratio
3.4.1 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fragment-based Drug Discovery Revenue in 2022
3.5 Fragment-based Drug Discovery Key Players Head office and Area Served
3.6 Key Players Fragment-based Drug Discovery Product Solution and Service
3.7 Date of Enter into Fragment-based Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fragment-based Drug Discovery Breakdown Data by Type
4.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2018-2023)
4.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2024-2033)
5 Fragment-based Drug Discovery Breakdown Data by Application
5.1 Global Fragment-based Drug Discovery Historic Market Size by Application (2018-2023)
5.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Fragment-based Drug Discovery Market Size (2018-2033)
6.2 North America Fragment-based Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Fragment-based Drug Discovery Market Size by Country (2018-2023)
6.4 North America Fragment-based Drug Discovery Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size (2018-2033)
7.2 Europe Fragment-based Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Fragment-based Drug Discovery Market Size by Country (2018-2023)
7.4 Europe Fragment-based Drug Discovery Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fragment-based Drug Discovery Market Size (2018-2033)
8.2 Asia-Pacific Fragment-based Drug Discovery Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2018-2023)
8.4 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fragment-based Drug Discovery Market Size (2018-2033)
9.2 Latin America Fragment-based Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Fragment-based Drug Discovery Market Size by Country (2018-2023)
9.4 Latin America Fragment-based Drug Discovery Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fragment-based Drug Discovery Market Size (2018-2033)
10.2 Middle East & Africa Fragment-based Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2018-2023)
10.4 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Detail
11.1.2 Astex Pharmaceuticals Business Overview
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Introduction
11.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.1.5 Astex Pharmaceuticals Recent Development
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Detail
11.2.2 Alveus Pharmaceuticals Business Overview
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Introduction
11.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.2.5 Alveus Pharmaceuticals Recent Development
11.3 Beactica
11.3.1 Beactica Company Detail
11.3.2 Beactica Business Overview
11.3.3 Beactica Fragment-based Drug Discovery Introduction
11.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.3.5 Beactica Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Detail
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Introduction
11.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.4.5 Charles River Laboratories Recent Development
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Detail
11.5.2 Crown Bioscience Business Overview
11.5.3 Crown Bioscience Fragment-based Drug Discovery Introduction
11.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.5.5 Crown Bioscience Recent Development
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Detail
11.6.2 Emerald BioStructures Business Overview
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Introduction
11.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.6.5 Emerald BioStructures Recent Development
11.7 Evotec
11.7.1 Evotec Company Detail
11.7.2 Evotec Business Overview
11.7.3 Evotec Fragment-based Drug Discovery Introduction
11.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.7.5 Evotec Recent Development
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Detail
11.8.2 Kinetic Discovery Business Overview
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Introduction
11.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.8.5 Kinetic Discovery Recent Development
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Detail
11.9.2 Proteros Fragments Business Overview
11.9.3 Proteros Fragments Fragment-based Drug Discovery Introduction
11.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.9.5 Proteros Fragments Recent Development
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Detail
11.10.2 Sprint Bioscience Business Overview
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Introduction
11.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.10.5 Sprint Bioscience Recent Development
11.11 Structure Based Design
11.11.1 Structure Based Design Company Detail
11.11.2 Structure Based Design Business Overview
11.11.3 Structure Based Design Fragment-based Drug Discovery Introduction
11.11.4 Structure Based Design Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.11.5 Structure Based Design Recent Development
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Company Detail
11.12.2 Sygnature Discovery Business Overview
11.12.3 Sygnature Discovery Fragment-based Drug Discovery Introduction
11.12.4 Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.12.5 Sygnature Discovery Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Fragment Screening
Table 3. Key Players of Fragment Optimization
Table 4. Global Fragment-based Drug Discovery Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Fragment-based Drug Discovery Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Fragment-based Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Fragment-based Drug Discovery Market Share by Region (2018-2023)
Table 8. Global Fragment-based Drug Discovery Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Fragment-based Drug Discovery Market Share by Region (2024-2033)
Table 10. Fragment-based Drug Discovery Market Trends
Table 11. Fragment-based Drug Discovery Market Drivers
Table 12. Fragment-based Drug Discovery Market Challenges
Table 13. Fragment-based Drug Discovery Market Restraints
Table 14. Global Fragment-based Drug Discovery Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Fragment-based Drug Discovery Market Share by Players (2018-2023)
Table 16. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2022)
Table 17. Ranking of Global Top Fragment-based Drug Discovery Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Fragment-based Drug Discovery Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fragment-based Drug Discovery Product Solution and Service
Table 21. Date of Enter into Fragment-based Drug Discovery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Fragment-based Drug Discovery Revenue Market Share by Type (2018-2023)
Table 25. Global Fragment-based Drug Discovery Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Fragment-based Drug Discovery Revenue Market Share by Type (2024-2033)
Table 27. Global Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Fragment-based Drug Discovery Revenue Market Share by Application (2018-2023)
Table 29. Global Fragment-based Drug Discovery Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Fragment-based Drug Discovery Revenue Market Share by Application (2024-2033)
Table 31. North America Fragment-based Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Fragment-based Drug Discovery Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Fragment-based Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Fragment-based Drug Discovery Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Fragment-based Drug Discovery Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Fragment-based Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Fragment-based Drug Discovery Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Fragment-based Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2024-2033) & (US$ Million)
Table 46. Astex Pharmaceuticals Company Detail
Table 47. Astex Pharmaceuticals Business Overview
Table 48. Astex Pharmaceuticals Fragment-based Drug Discovery Product
Table 49. Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 50. Astex Pharmaceuticals Recent Development
Table 51. Alveus Pharmaceuticals Company Detail
Table 52. Alveus Pharmaceuticals Business Overview
Table 53. Alveus Pharmaceuticals Fragment-based Drug Discovery Product
Table 54. Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 55. Alveus Pharmaceuticals Recent Development
Table 56. Beactica Company Detail
Table 57. Beactica Business Overview
Table 58. Beactica Fragment-based Drug Discovery Product
Table 59. Beactica Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 60. Beactica Recent Development
Table 61. Charles River Laboratories Company Detail
Table 62. Charles River Laboratories Business Overview
Table 63. Charles River Laboratories Fragment-based Drug Discovery Product
Table 64. Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 65. Charles River Laboratories Recent Development
Table 66. Crown Bioscience Company Detail
Table 67. Crown Bioscience Business Overview
Table 68. Crown Bioscience Fragment-based Drug Discovery Product
Table 69. Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 70. Crown Bioscience Recent Development
Table 71. Emerald BioStructures Company Detail
Table 72. Emerald BioStructures Business Overview
Table 73. Emerald BioStructures Fragment-based Drug Discovery Product
Table 74. Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 75. Emerald BioStructures Recent Development
Table 76. Evotec Company Detail
Table 77. Evotec Business Overview
Table 78. Evotec Fragment-based Drug Discovery Product
Table 79. Evotec Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 80. Evotec Recent Development
Table 81. Kinetic Discovery Company Detail
Table 82. Kinetic Discovery Business Overview
Table 83. Kinetic Discovery Fragment-based Drug Discovery Product
Table 84. Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 85. Kinetic Discovery Recent Development
Table 86. Proteros Fragments Company Detail
Table 87. Proteros Fragments Business Overview
Table 88. Proteros Fragments Fragment-based Drug Discovery Product
Table 89. Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 90. Proteros Fragments Recent Development
Table 91. Sprint Bioscience Company Detail
Table 92. Sprint Bioscience Business Overview
Table 93. Sprint Bioscience Fragment-based Drug Discovery Product
Table 94. Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 95. Sprint Bioscience Recent Development
Table 96. Structure Based Design Company Detail
Table 97. Structure Based Design Business Overview
Table 98. Structure Based Design Fragment-based Drug Discovery Product
Table 99. Structure Based Design Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 100. Structure Based Design Recent Development
Table 101. Sygnature Discovery Company Detail
Table 102. Sygnature Discovery Business Overview
Table 103. Sygnature Discovery Fragment-based Drug Discovery Product
Table 104. Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 105. Sygnature Discovery Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fragment-based Drug Discovery Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Fragment-based Drug Discovery Market Share by Type: 2022 VS 2033
Figure 3. Fragment Screening Features
Figure 4. Fragment Optimization Features
Figure 5. Global Fragment-based Drug Discovery Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Fragment-based Drug Discovery Market Share by Application: 2022 VS 2033
Figure 7. Academic and Research Institutions Case Studies
Figure 8. Biopharmaceutical Companies Case Studies
Figure 9. Contract Research Organizations (CROs) Case Studies
Figure 10. Fragment-based Drug Discovery Report Years Considered
Figure 11. Global Fragment-based Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Fragment-based Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Fragment-based Drug Discovery Market Share by Region: 2022 VS 2033
Figure 14. Global Fragment-based Drug Discovery Market Share by Players in 2022
Figure 15. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2022
Figure 17. North America Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Fragment-based Drug Discovery Market Share by Country (2018-2033)
Figure 19. United States Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Fragment-based Drug Discovery Market Share by Country (2018-2033)
Figure 23. Germany Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Fragment-based Drug Discovery Market Share by Region (2018-2033)
Figure 31. China Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Fragment-based Drug Discovery Market Share by Country (2018-2033)
Figure 39. Mexico Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Fragment-based Drug Discovery Market Share by Country (2018-2033)
Figure 43. Turkey Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Fragment-based Drug Discovery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 46. Alveus Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 47. Beactica Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 48. Charles River Laboratories Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 49. Crown Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 50. Emerald BioStructures Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 51. Evotec Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 52. Kinetic Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 53. Proteros Fragments Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 54. Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 55. Structure Based Design Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 56. Sygnature Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed